Pharma Direct-to-consumer Ad Spending in US Jumps to $4.53 Billion


The pharmaceutical industry spent $4.53 billion on direct-to-consumer advertising in the US in 2014, up 18% from $3.83 billion in 2013, reports FiercePharma.

Pharma’s ad spend vaults to $4.5B, with big spender Pfizer leading the way (FiercePharma, March 25, 2015)

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time


  1. Pharmaceutical corporations exist to grow make profits by virtually any means they can get away with. They are not held to moral or ethical standards. Therefore, they should not be allowed to dupe ordinary people (typically unwell people no less) with deceptive advertising.

    Report comment

  2. Only two countries permit pharmaceutical companies to buy direct-to-consumer advertising – the U.S. and New Zealand.

    Yet another good reason not to watch TV (or to use TIVO to dump the ads). As for “women’s” magazines – don’t read those unless you want to know why you should Ability to your anti-depressant – if the anti-depressaant isn’t working.

    Report comment